Mulberrin Alleviates Renal Ischemia–Reperfusion by Inhibiting Ferroptosis and Oxidative Stress Through Sirt3 Activation
<b>Background:</b> Renal ischemia-reperfusion (I/R) injury represents a principal etiologic factor in acute kidney injury (AKI), in which ferroptosis plays a critical role. Mulberrin (Mul), a prenylated flavonoid with antioxidative properties, has an as-yet undefined role in renal I/R injury. <b>Methods:</b> We established a mouse renal IRI model and an HK-2 H/R system. Renal function, histological injury, oxidative stress, ferroptosis markers, and mitochondrial function were assessed. The role of Sirtuin 3 (Sirt3) in Mul-mediated effects was further examined using siRNA knockdown in HK-2 cells. <b>Results:</b> The administration of Mul led to a marked improvement in renal function, lessened tubular injury, and reduced apoptosis in IRI mice. Mul also restored GSH levels, decreased MDA and Fe<sup>2+</sup> accumulation, and normalized expression of ferroptosis-related proteins, thereby suppressing ferroptosis. In H/R-injured HK-2 cells, Mul restored mitochondrial membrane potential, increased ATP production, and reduced ROS accumulation. Mechanistically, Mul markedly upregulated Sirt3 expression, and silencing Sirt3 abolished its antioxidant and anti-ferroptosis effects, confirming the essential role of Sirt3 in Mul-mediated protection. <b>Conclusions:</b> Our findings underscore Mul's therapeutic promise in acute kidney injury and provide a mechanistic foundation for interventions directed at the Sirt3-ferroptosis pathway to safeguard renal function.
Authors
- Tao Qiu (ORCID: https://orcid.org/0000-0002-1410-7795)
- Wen‐Bin Yang (ORCID: https://orcid.org/0000-0002-6497-4176)
- Jiangqiao Zhou (ORCID: https://orcid.org/0000-0002-6118-0020)
- Nan Jiang (ORCID: https://orcid.org/0000-0002-7661-5728)
- Bo Yu (ORCID: https://orcid.org/0000-0002-2045-8567)
- Qiangmin Qiu
- Jiahao Jiang (ORCID: https://orcid.org/0009-0009-5712-5289)
- Yujie Zhou (ORCID: https://orcid.org/0000-0002-9545-1984)
- Dalin He (ORCID: https://orcid.org/0000-0002-8099-146X)
- Yifan Lu (ORCID: https://orcid.org/0000-0003-4461-0698)
- Zhan Chen (ORCID: https://orcid.org/0009-0002-6039-0584)
Institutions
- Wuhan University (CN)
- Renmin Hospital of Wuhan University (CN)
Publication Details
- Journal
- Biomedicines
- Published
- 2025-10-31
- DOI
- https://doi.org/10.3390/biomedicines13112687
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00